Comparison of the Immunogenicity and Safety of Various Investigational and Licensed Formulations of Hepatitis B Surface Antigen (HBsAg) Vaccines
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2016
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 07 Jun 2017 Biomarkers information updated
- 02 Aug 2012 Actual end date (1 Jul 2011) added as reported by ClinicalTrials.gov record.
- 28 Jan 2011 Planned end date changed from 1 Aug 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.